We are a spin-off from the Swiss Federal Institute of Technology in Lausanne (EPFL), founded in Switzerland in 2019. We provide cutting-edge laboratory equipment
Basel, Switzerland – 6 September 2023, Alentis Therapeutics ( Alentis”), a clinical-stage biotechnology company developing treatments for Claudin-1 positive (CLDN1+)
We would like to see in Switzerland more seasoned investors to think big and take risks for international business – Stiftung Pro Zukunftsfonds Schweiz